Salt Composition in both
Salt Composition
Finasteride 1mg(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Finaworth 1mg Tablet 10s
432+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
=Flag your dependable, reliable products on the marketplace the same as in sales? The prices mentioned here are prescription drug approves. Perphthalmic drops are manufactured by Flush Chemist, a specialty pharmaceutical company. We only sell the best substitute from top brands. This offers reassurance that it is effective, safe and costeffective.mittedly, we canChance a dollar or two above the market average for the quality of the product. We ensure that the product is safe, effective, andnasal for distributors and patients. If you have any questions about the price,, please can contact the manufacturer. Flush Chemist makes it's products available on IFFRITest price possible, when youipedia.com is considered a valid distributors order.Our goal is to provide access to this drug to patients with specific medical conditions and, potentially, to those at risk. It is important to take this medication only by prescription.
The FDA has approved a generic version of Propecia® (finasteride) for use in the treatment of benign prostatic hyperplasia (BPH). This approval will allow finasteride to be used as a first-line therapy for patients who have BPH, but do not have an enlarged prostate, with or without prostate cancer. Propecia® is also approved to reduce the risk of hair loss in men who use it for a number of reasons, such as for hair regrowth. The generic version of Propecia® will also have the same active ingredient, finasteride, as the brand-name version. Both versions of Propecia® are available on the brand-name drugstore. The brand-name drugstore also sells generic finasteride.
We currently have no data to show that the generic version of Propecia® will be available in the United States. The generic version of Propecia® is not currently available in the United States.
This data is for information purposes only and is not a substitute for the medical advice provided by your health care professional. If you have any questions or concerns about your health, please discuss your medical history and other relevant information with your health care professional.
This product does not apply to men who are:
Tell all your health care providers you are going to and who may need this medication. You can call your health care provider if you have a need for this medication in person. You may need to take it with or without food.
The recommended dose is one tablet (30 mg) once daily. If you are taking medication that affects the blood clotting abilities of this product, you should stop taking it as soon as possible and tell the doctor or pharmacist. Your doctor or pharmacist may prescribe a different dose depending on whether you take it with or without food.
Read the Patient Information Leaflet if available from your health care provider before you start taking finasteride and each time you get a refill. Do not take this medicine more than once daily. Keep taking it unless the doctor stops the medication. Never stop using it suddenly and sharply, and notify your health care provider of any changes in your health that may be affecting your dose or how well you fare. You must periodically reassess whether it is still effective.
Your healthcare provider will tell you how many tablets to take each day and will also give you instructions on how to store this medicine. Read the Leaflet if it has any information that would be of benefit to you.
Finasteride has been shown to cause sexual side effects in men who use it for a number of reasons, such as for hair growth.
Sexual side effects are more common in men who take finasteride for the treatment of hair loss. The following side effects are not dangerous and will go away on their own without medical attention:
Sexual side effects are generally well tolerated and usually go away on their own. However, in some men who use this drug, low sexual activity may lead to erections and/or difficulty having an erection that lasts for several hours or even days. Sexual problems can also occur during or after treatment with this drug. For example, in men who used it for a number of years, sexual problems such as problems with the erections, may have been treated with finasteride. Sexual problems are also known as impotence or impotence problems. If low sexual activity does not resolve the sexual problems, talk to your healthcare provider. You may be asked to have sex again.
Sexual side effects may be temporary or permanent.
Finasteride, a drug used for treating benign prostatic hyperplasia, is associated with significant risk of prostate cancer. Several studies have shown that finasteride could be an effective treatment for benign prostatic hyperplasia. However, the available data concerning finasteride use in prostate cancer prevention are limited. We conducted a systematic review to determine the effect of finasteride use in benign prostate hyperplasia, evaluating its relationship to the risk of prostate cancer. A total of 841 men with benign prostatic hyperplasia were enrolled in a prospective cohort study of 6 months. The primary outcome was the presence of prostate cancer (defined as the presence of Gleason score ≤7) at the time of enrollment, and the secondary outcome was the incidence of prostate cancer at the time of enrollment. The primary and secondary outcomes were based on the International Prostate Symptom Score (IPSS), the International Prostate Symptom Score (IPSS), and the International Prostate Symptom Score (IPSS) from baseline to endpoint. Compared to baseline, prostate cancer at baseline was more frequent in men taking finasteride than in those on placebo (4.5% vs 2.2%). The incidence of prostate cancer at baseline was lower among men taking finasteride than men taking placebo (23.3% vs 19.4%) and those on finasteride and finasteride vs placebo (28.7% vs 33.3%). Compared to men on placebo, the incidence of prostate cancer was significantly higher among men taking finasteride vs finasteride (28.7% vs 23.3%) (P<0.001). The incidence of prostate cancer was lower among men taking finasteride vs finasteride (7.2% vs 4.5%) (P<0.001) and was lower among men taking finasteride vs placebo (2.2% vs 1.8%) (P<0.001) (Table 1). The risk of prostate cancer in men taking finasteride was also significantly lower than placebo in men taking finasteride (10.8% vs 5.9%), but not in men taking finasteride vs placebo (Table 2). Based on our data, finasteride is not an effective treatment for benign prostatic hyperplasia, and the available data suggest that finasteride use should be avoided in men with prostate cancer.
Citation:Rosenbaum A, Cuzick L, Pichler S, Stearns A, et al. (2020) Finasteride Use in Benign Prostatic Hyperplasia: Results of a Prospective Cohort Study. PLoS ONE 10(5): e0164119. https://www.pone.pk/?nid3964119. Accessed 20 January 2025
A comprehensive analysis of the effects of finasteride on prostate cancer in benign prostatic hyperplasia was performed. We found that finasteride may be associated with a significant risk of prostate cancer in men with benign prostatic hyperplasia. Finasteride use has been associated with the risk of prostate cancer, but the available data for the association between finasteride use and prostate cancer are limited. Our study aimed to determine the effect of finasteride on the risk of prostate cancer among men with benign prostatic hyperplasia. We analyzed the available data from the Prostate Cancer Prevention Trial (PCPT) and published the results in the current issue. Our results suggest that finasteride use was not associated with a significantly increased risk of prostate cancer. Finasteride is generally not recommended in men with benign prostatic hyperplasia due to the potential for a higher risk of developing prostate cancer. Therefore, it is recommended that patients with a history of prostate cancer should be screened for prostate cancer before initiating finasteride therapy. Our study findings suggest that finasteride use was associated with an increased risk of prostate cancer. Our findings also suggested that finasteride use was not associated with a significantly increased risk of prostate cancer. Based on the available data, finasteride is not recommended for patients with benign prostatic hyperplasia. We conclude that finasteride use should be avoided in patients with benign prostate hyperplasia, and finasteride use should be avoided in men with prostate cancer. Therefore, finasteride is not recommended in men with prostate cancer.
Keywords:Finasteride, prostate cancer, prostate cancer, prostate cancer, benign prostate hyperplasia, finasteride, prostate cancer, prostate cancer.
Finasteride is a widely used drug for the treatment of benign prostatic hyperplasia and the prevention of prostate cancer.
Finasterideis the generic drug for. Finasteride is the active ingredient in the brand name drug finasteride. Finasteride is also the active ingredient in the brand name drug Propecia, which is used to treat male pattern baldness and prostate gland enlargement. This drug was approved by the US Food and Drug Administration (USFDA) for the treatment of male pattern baldness, but it is not for the treatment of prostate gland enlargement. Finasteride was the active ingredient in the brand name drug Proscar, which was approved by the US FDA for the treatment of benign prostatic hypertrophy. Finasteride is the active ingredient in the brand name drug Propecia, which is used to treat male pattern baldness and prostate gland enlargement. Finasteride is the active ingredient in the brand name drug Proscar, which was approved by the US FDA for the treatment of benign prostatic hypertrophy. Finasteride is the active ingredient in the brand name drug Propecia, which was approved by the US FDA for the treatment of male pattern baldness and prostate gland enlargement. Finasteride is the active ingredient in the brand name drug Propecia, which was approved by the US FDA for the treatment of benign prostatic hypertrophy. The drug is manufactured by the Merck Group. It is also the active ingredient in the brand name drug Propecia, which was approved by the US FDA for the treatment of benign prostatic hypertrophy. It is a drug used to treat male pattern baldness. It is the active ingredient in the brand name drug Propecia, which was approved by the US FDA for the treatment of benign prostatic hypertrophy. It is used to treat male pattern baldness.
We have with us superior qualityFinpecia / Finasteride Tabletswhich are well known among our customers for their high efficiency and negligible side effects. Our offered medicines are primarily used as treatment for prostate under doctors guidance in various hospitals and clinics. We procure these medicines from trustworthy vendors, which makes them pure and precisely formulated.
Mehadia Tradelinks is the leading exporter of pharmaceutical products and medicines in India.We provide the best quality medicines and quick services for all customers around the globe with all necessary tracking information of the products.We are a specialist in Finasteride Tablets like Finast, Finpecia, Finalo and many more.
We have strong global networks in United States, Europe, United Kingdom, China, Japan, Russia, Ukraine, Dubai, Unites Arab Emirates, Thailand, Vietnam, Africa, Middle East and South East Countries.
Delivery Details :
Destination | Delivery Time |
India | 24-48 Hours |
China / Hong Kong / Singapore/ Malaysia | Within 4-5 Working Days |
Vietnam / Philipines / Indonesia | Within 6 Working Days |
Uk / Usa / Europe / South America / Uae / Canada / Australia & Rest Of The Countries | Within 7 Working Days |
Stade de France Pharmacy